Exclusive

Publication

Byline

Cipla sees weight-loss drugs as the biggest opportunity in the Indian market

Mumbai, July 25 -- Drugmaker Cipla Ltd anticipates GLP-1 drugs, used for treating type-2 diabetes and obesity, to be a definite new therapy in the Indian market, and is exploring a wider foray, said c... Read More


India-UK FTA to boost bilateral trade for pharma, medtech, say industry bodies

New Delhi, July 24 -- The India-UK free trade agreement, signed on Thursday, is expected to open up new opportunities for Indian pharmaceutical and medical device makers. The deal is also expected to ... Read More


Dr. Reddy's US generics business drags Q1 earnings, eyes weight-loss drug launch in 87 countries

New Delhi, July 23 -- Dr Reddy's Laboratories Ltd's US generics business slumped in the June quarter as it faced price erosion in key products like gRevlimid used to treat cancer. US generics revenue... Read More


Indian Pharma Q1FY26: Strong domestic sales to cushion weakness in US markets

New Delhi, July 23 -- India's pharmaceutical companies are expected to deliver steady earnings growth in the June quarter, buoyed by robust domestic demand despite pricing pressure in the US on key pr... Read More


Pharma giants want to crash the skincare party. It will be a long climb.

New Delhi, July 16 -- India's pharmaceutical giants have a battle on their hands as they take on beauty and cosmetic startups and their influencers. Consumers are increasingly seeking out clinically b... Read More


Pharma giants want to crash the skincare party. It will be a long haul.

New Delhi, July 16 -- India's pharmaceutical giants have a battle on their hands as they take on beauty and cosmetic startups and their influencers. Consumers are increasingly seeking out clinically b... Read More


Sun Pharma launches alopecia drug Leqselvi in US after settling patent dispute

New Delhi, July 14 -- Sun Pharma on Monday announced it has settled a patent row with American biopharma company Incyte Corporation over its hair-loss drug, paving the way for its launch in the US. Th... Read More


Wockhardt exits its US generics business

New Delhi, July 11 -- Wockhardt Ltd is exiting its loss-making US generics business, as it focuses on its new antibiotics drug discovery and insulin portfolios. The drugmaker said on Friday that it h... Read More


Glenmark unit clinches $700mn licensing deal for its cancer drug

New Delhi, July 10 -- A unit of Glenmark Pharmaceuticals Ltd is licensing its under-development blood cancer drug to Chicago-based AbbVie Inc. for $700 million, marking the biggest outlicensing deal f... Read More


Manipal buys Pune's Sahyadri Hospitals from Ontario Teachers for $760 mn

New Delhi, July 9 -- Three years after acquiring a controlling stake in Pune-based Sahyadri Hospitals, Ontario Teachers Pension Plan (OTPP) has sold the chain to Temasek-backed Manipal Hospitals as co... Read More